These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 3798868)

  • 21. Analysis of platelet-reactive alloantibodies and evaluation of cross-match-compatible platelets for the management of patients with transfusion refractoriness.
    Wang J; Xia W; Deng J; Xu X; Shao Y; Ding H; Chen Y; Liu J; Chen D; Ye X; Santoso S
    Transfus Med; 2018 Feb; 28(1):40-46. PubMed ID: 28516675
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stability of platelet and plasma HLA concentrations in healthy adults or random-donor platelet concentrates.
    Kao KJ
    Transfusion; 1989 May; 29(4):328-31. PubMed ID: 2718234
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Posttransfusion purpura following bone marrow transplantation.
    Evenson DA; Stroncek DF; Pulkrabek S; Perry EH; Radford J; Miller JS; Verfaillie C
    Transfusion; 1995 Aug; 35(8):688-93. PubMed ID: 7631411
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adhesive interaction between peripheral blood mononuclear cells and activated platelets in the presence of anti-human leukocyte antigen Class I alloantibody causes production of IL-1β and IL-8.
    Takahashi D; Fujihara M; Azuma H; Wakamoto S; Sato S; Kato T; Ikeda H
    Vox Sang; 2012 Apr; 102(3):250-7. PubMed ID: 21923858
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analysis of a high-throughput HLA antibody screening assay for use with platelet donors.
    Fadeyi E; Adams S; Peterson B; Hackett J; Byrne P; Klein HG; Marincola FM; Leitman SF; Stroncek DF
    Transfusion; 2008 Jun; 48(6):1174-9. PubMed ID: 18422853
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Platelet alloimmunization after multiple transfusions: a prospective study of 50 patients.
    Godeau B; Fromont P; Seror T; Duedari N; Bierling P
    Br J Haematol; 1992 Jul; 81(3):395-400. PubMed ID: 1390213
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A new platelet-specific antigen, Naka, involved in the refractoriness of HLA-matched platelet transfusion.
    Ikeda H; Mitani T; Ohnuma M; Haga H; Ohtzuka S; Kato T; Nakase T; Sekiguchi S
    Vox Sang; 1989; 57(3):213-7. PubMed ID: 2617957
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HLA (class I) antigens on platelets are involved in platelet function.
    Cosgrove LJ; Vaughan HA; Tjandra JJ; Thurlow PJ; McKenzie IF
    Immunol Cell Biol; 1988 Feb; 66 ( Pt 1)():69-77. PubMed ID: 3372006
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Results of HLA antibody testing using ELISA vs the fluorescent bead method and retrospective review of data for recipients of packed RBCs and platelets from male HLA-immunized donors.
    Aung FM; Cano P; Fernandez-Vina M; Lichtiger B
    Am J Clin Pathol; 2011 Jan; 135(1):90-5. PubMed ID: 21173129
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of HLA-B12 on platelets, on lymphocytes and in serum: a quantitative study.
    Liebert M; Aster RH
    Tissue Antigens; 1977 Apr; 9(4):199-208. PubMed ID: 69335
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biotin-avidin immobilization of platelet glycoproteins (BAIPG): a new capture assay for the detection of anti-platelet antibodies.
    Cordiano I; Steffan A; Randi ML; Pradella P; Girolami A; Fabris F
    J Immunol Methods; 1995 Jan; 178(1):121-30. PubMed ID: 7829861
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Platelet immunology. ELISA for detection of platelet antibodies, platelet-specific antigens and platelet glycoproteins.
    Taaning E
    Dan Med Bull; 1992 Aug; 39(4):343-54. PubMed ID: 1382006
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Thrombocyte transfusion: increase in platelets in relation to clinical and immunologic prerequisites].
    Panzer S; Maier F; Höcker P; Mayr WR; Hinterberger W
    Infusionsther Klin Ernahr; 1987 Apr; 14 Suppl 2():10-4. PubMed ID: 3298059
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Experience of HLA-matched platelet transfusion in patients who are refractory to random donor platelets].
    Sekiguchi S; Mitani T; Ohnuma M; Katoh T; Ikeda H; Nakase T; Morioka M; Sakurada K; Miyazaki T
    Hokkaido Igaku Zasshi; 1988 Jul; 63(4):552-61. PubMed ID: 3220437
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The transfusion of HLA-matched platelets to thrombocytopenic patients resistant to random donor platelets.
    Levy L; Woodfield DG
    N Z Med J; 1984 Oct; 97(766):719-21. PubMed ID: 6595558
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The origin of HLA antigens in thrombocytes].
    Korínková P
    Vnitr Lek; 1989 Sep; 35(9):880-4. PubMed ID: 2683366
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Platelet crossmatching. A direct approach to the selection of platelet transfusions for the alloimmunized thrombocytopenic patient.
    Kickler TS; Ness PM; Braine HG
    Am J Clin Pathol; 1988 Jul; 90(1):69-72. PubMed ID: 3389345
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Substitution ofpolysensitized patients with platelets from HL-A typed single donors].
    Gmür J; Baumberger U; von Felten A
    Schweiz Med Wochenschr; 1976 Oct; 106(40):1358-9. PubMed ID: 1006253
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [HLA and transfusion: new approaches with Luminex™ technology].
    Giannoli C; Nguyen TK; Dubois V
    Transfus Clin Biol; 2011 Apr; 18(2):218-23. PubMed ID: 21397543
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Successful management of alloimmunized patients by transfusing HLA compatible and crossmatched platelets.
    Yung CH; Chow MP; Hu HY; Tzeng JL; Mou LL; Deng JM
    Zhonghua Yi Xue Za Zhi (Taipei); 1991 Apr; 47(4):228-36. PubMed ID: 1646671
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.